Medical Press Release - Page 7 of 12 - Medika Life : Keeping you informed

An important part of the brain's immune system, cells called microglia constantly extend and retract "branches" from their cell body to survey their environment.

Study Reveals Networks of Genes Involved in Congenital Heart Disease

Medika Life - December 15, 2020

Over two million babies, children, and adults in the United States are living with congenital heart disease—a range of birth defects affecting the heart's structure or function

First Hospitals in U.S. Implant Next-gen Cardiac Device to Reduce Stroke Risk

Medika Life - August 8, 2020

The WATCHMAN FLX is the only FDA-approved device for the reduction of stroke risk in patients with non-valvular atrial fibrillation (A Fib).

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life - August 12, 2020

SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

AI-Driven Model Supports Safer and More Precise Blood Sugar Management After Heart Surgery

Corundum Convergence Institute Launches to Catalyze Funding for Research and Innovation in Neuroscience and Systems Biology

StuffThatWorks and The Marfan Foundation to Engage in Pilot Program

Intellihealth Chief Medical Officer, Dr. Leon Igel, Honored as American Diabetes Association Greater New York Research Dinner Medical Honoree of the Year

LATEST

TRENDING

Medika’s Call for Food Aid for Starving Filipino Children

Lover, the App That Helps Women Reach Orgasm

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

The Nation’s Only Virtual At-Home Detox Programs from Workit Health Expands

The 50 Most Influential Leaders in Pharmacy 2022 Awards

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

Parnell Pharmaceuticals Announces Nomovid™ Antiviral Nasal Spray

Children with no COVID-19 symptoms may shed virus for weeks

South University Announces New MSPA Program at West Palm Beach Campus

EDITORS CHOICE

An Unexpected Role for the Brain’s Immune Cells

Study Reveals Networks of Genes Involved in Congenital Heart Disease

First Hospitals in U.S. Implant Next-gen Cardiac Device to Reduce Stroke Risk

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories